PS-341 (bortezomib)

bortezomib · Millennium Pharmaceuticals

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PS-341 (bortezomib), covering 2009-12-15 to 2013-06-18. Get the full timeline:

Most recent: Clinical Trial Update: PS-341 in Treating Patients With Hematologic Cancer [Phase 1]